NEW YORK (360Dx) — Genspeed announced today that it has partnered with Danish medical technology firm Virogates to develop a rapid point-of-care test for medical risk classification.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.